he sarcoplasmic reticulum (SR) is a tubular, membranous network within muscle cells, which is the analogue of the endoplasmic reticulum (ER) in other cells. This organelle has a variety of functions, of which release of Ca 2+ to the cytosol and reuptake into the interior compartment (the lumen) of the SR are the most important. Rapid release of Ca 2+ through a Ca 2+ release channel (ryanodine receptor) in the skeletal muscle SR is responsible for muscle contraction: reuptake of Ca 2+ by the action of a Ca 2+ -ATPase is responsible for muscle relaxation. In cardiac muscle, however, the intracellular Ca 2+ concentration is controlled not only by the SR, but also by other pumps, channels, and exchangers located in the sarcolemma/T-tubules. Nonetheless, the SR of mammalian cardiac cells is well developed and has a major role in the EC coupling. 1,2 In the SR of cardiac muscle, as well as in slow-twitch skeletal and smooth muscles, phospholamban (PLN) participates in the EC coupling processes by regulating the activity of the Ca 2+ -ATPase. Of particular interest is the molecular mode of PLN-mediated regulation of SR Ca 2+ -ATPase, in which cAMP-dependent protein kinase (PKA)-catalyzed phosphorylation of PLN results in marked augmentation of the Ca 2+ -ATPase activity. 1,3 The molecular structure and function of the 2 important proteins in cardiac SR are highlighted in this review: Ca 2+ -ATPase and PLN and their molecular interactions, which would help understand the positive and negative inotropic effects of -adrenergic agonist/antagonist. The pathophysiological consequences of molecular perturbation of such a system are also briefly mentioned, leading to an evolving notion that 'calcium cycling defects' underlie cardiac hypertrophy and failure.
ATP to form intermediary steps involving the formation and hydrolysis of a phosphoenzyme intermediate (acyl phosphorylation at its Asp 351 ); several conformational steps have been identified, which are coupled with translocation of Ca 2+ across the SR membranes. Three isoforms of the SERCAs are encoded by 3 separate genes, ATP2A1, ATP2A2, and ATP2A3, which encode SERCA1, 2, and 3, respectively (Table 1) . Although SERCA1 is expressed in the SR of fasttwitch skeletal muscle, SERCA2 is expressed in cardiac muscle, as well as in slow-twitch skeletal and smooth muscles. SERCA3 is expressed in a broad variety of muscle and non-muscle tissues; this type of Ca 2+ -ATPase is thus considered to serve as a housekeeping enzyme. Of alternatively spliced SERCA1 gene transcripts, SERCA1a with 994-aa is expressed in adult muscle cells, and SERCA1b with 1011-aa is a neonatal form. In SERCA2, the SERCA2a transcript with 997-aa is expressed in cardiac and slowtwitch skeletal muscles, whereas the SERCA2b transcript is expressed in smooth muscle and non-muscle tissues. As of now, only one PLN gene has been found and is expressed in cardiac, slow-twitch skeletal, and smooth muscles. Therefore, in cardiac muscle SR, there is always co-expression of the SERCA2a (ATP2A2) and PLN genes. PLN, a 52-aa integral SR membrane protein was first found by Tada et al (i) to be phosphorylated by cAMP-PK at its Ser 16 (phosphoester phosphorylation), and (ii) to control SERCA2a Ca 2+ -pump ATPase activity. Calumodulin (CaM) kinase II was subsequently found to catalyze phosphorylation of PLN at Thr 17 ; 4,5 operationally, dual phosphorylation at these positions can occur, resulting in additive effects on the Ca 2+ pumping function, 5 as will be mentioned later. Of molecular genetic interest is the switching of the transcriptional regulation of the PLN and SERCA genes in a fast-to-slow transition system. In fast-twitch skeletal muscle subjected to chronic low-frequency electrical stimulation, to switch to the slow-twitch type, the isoform transition of SERCA2 mRNA from the SERCA1 isoform was accompanied by the distinct appearance of PLN mRNA. Switching of other protein mRNA isoforms, such as myosin light and heavy chains, was found to occur simultaneously. forms eventually provided the primary sequences of each of these Ca 2+ -ATPases. Complete sequencing of SERCA1a and 1 b in 1986 and 1987, respectively, was immediately followed by that of SERCA2a and 2b. 7 Thus, analysis of the primary sequences of SERCA1 and SERCA2 provided the first predicted topological and secondary structural model of P-type ATPases (Fig 1) . In this model, 10 relatively hydrophobic sequences span the lipid bilayer in helical conformations with a small number of amino acids exposed to the lumen of the SR. Most of the remainder of the molecule forms cytoplasmic NH2 and COOH terminal sequences: 2 domains forming a cytoplasmic, globular headpiece structure are connected to the transmembrane sequences through 5 -helices, which are clustered to form a stalk-like structure. Mapping studies to localize immunologically reactive epitopes on potentially exposed luminal loops and ligand binding studies supported the 10-helices model.
Predictions of the secondary structure for the long cytoplasmic peptide loop between membrane-spanning segments M2 and M3 suggest that it folds into an anti-parallel -strand domain, containing several sequences that are highly conserved among P-type ATPases. The long hydrophilic segment between membrane-spanning segments M4 and M5 is predicted to consist of alternating -helices and -strands, which would form parallel-stranded -sheet structures analogous to those in other nucleotide-binding domains. This cytoplasmic sequence contains both Asp 351 , the site of catalytic phosphorylation by ATP, and those residues predicted to comprise the nucleotide-binding site, as well as residues that have been proven to comprise the PLN-binding site, as is shown later.
Three-Dimensional Structure of the Ca 2+ -ATPase
The 3-dimensional structure of SERCA1 at 14 Å resolution has been determined from 2-dimensional crystals in a tubular array, using cryoelectron microscopy and helical image analysis. 8 The Ca 2+ -ATPase appears to be a tall molecule consisting of cytoplasmic, transmembrane, and luminal parts, with much of the mass distributed on the cytoplasmic surface of the lipid bilayer. The cytoplasmic part resembles the head and neck of a bird. The 'head', probably forming ATP binding and phosphorylation domains, is connected to the transmembrane domain through the 'neck'. The ATP binding site is proposed to lie in a groove formed by 3 cytoplasmic densities surrounding the 'beak' in the bird-like model of the headpiece. The 3-dimensional structure of SERCA1 at 8 Å resolution, obtained by improved processing images, revealed clusters of rodlike densities in the transmembrane domain that presumably correspond to the -helices. 9 Together with the results of site-directed mutagenesis, which localized the Ca 2+ binding sites between M4, M5, and M6, 10, 11 and from disulfide links between pairs of cysteine introduced into M4 and M6, the most favored assignments of these transmembrane helices M4, M5, and M6 were proposed to form a right-hand-coiled structure surrounding the distinctive cavity. The Ca 2+ -bound structure documented by crystallographic analysis at 2.6 Å resolution by Toyoshima et al offers many more insights into the mechanism of action of Ca 2+ -ATPase. 12 They identified new ligands, particularly mutation-sensitive backbone carbonyl groups on transmembrane helix M4, and a single water molecule, in the Ca 2+ binding site, together with possible entry and exit pathways for Ca 2+ that are lined by oxygen atoms. A distinctive feature of this region is the disruption of the M4 and M6 helices to form a Ca 2+ -binding cavity. This was anticipated from earlier NMR studies of helix M6, and means that structural changes in the carbonyl termini of M4 and M6 may be the key to creating and closing off access to the Ca 2+ -binding cavity. It will be of the utmost significance to examine how PLN can fit into the M4-M6 structures when co-crystallographic analysis of PLN/SERCA2a becomes available. To sustain active Ca 2+ transport, the ATPase enzyme must alternate between at least 2 states with a different affinity for Ca 2+ and with opposite orientation of the Ca 2+ binding sites with respect to the plane of the membrane. The reaction cycle is generally described according to a model with 2 major states, E1 and E2 16 {Tada, 1982 #422}, as shown in Fig 2 . In this equation model, vectorial transport against a gradient of the cation Ca 2+ can most readily be visualized as a transition between 2 conformations of the enzyme. The E1 state of the ATPase enzyme has highaffinity Ca 2+ binding sites, which face the cytoplasmic side of the membrane and are exposed to relatively lower concentrations of Ca 2+ . The E2 state has low-affinity Ca 2+ binding sites, which face the opposite side of the membrane and are, therefore, exposed to a higher concentration of Ca 2+ . Micromolar Ca 2+ stabilizes the E1 conformation of the enzyme, whereas removal of Ca 2+ from the medium at low pH and high temperature, or addition of vanadate, stabilizes the E2 conformation. 16 In the presence of saturating Mg 2+ and neutral pH at 25°C, the Kca for the highaffinity Ca 2+ binding sites of the enzyme (E1) is estimated to be 10 -6 mol/L, whereas the Kca for the low-affinity Ca 2+ binding sites of the enzyme (E2) is estimated to be less than 10 -7 mol/L. In the initial step of the Ca 2+ transport cycle, 2 Ca 2+ ions and 1 ATP bind to the enzyme (E1) from the cytoplasmic side of the membrane (step i). When thephosphate of ATP is covalently bound to Asp 351 of the enzyme, forming the phospho-enzyme (2Ca 2+ oE1ATP), Ca 2+ becomes occluded and can no longer be dissociated to either side of the membrane (step ii). To this point, the reaction is reversible, because chemical energy is still conserved in the phosphoryl bond. The phosphoryl group can thus be transferred back to ADP to make ATP, accompanied by deocclusion of the bound Ca 2+ . The next step (step iii) is the conformational transition between an ADP-sensitive phosphoenzyme intermediate, (2Ca 2+ iE1P) and an ADP-insensitive phosphoenzyme intermediate (E2P). The conversion of the phosphoenzyme from a high-energy state to a low-energy state is coupled to the movement of Ca 2+ from high-affinity binding sites facing the cytoplasmic side to low-affinity binding sites facing the luminal surface of the membrane. Ca 2+ is now dissociated from the enzyme to the luminal side of the membrane. At step iv, the lowenergy phosphoenzyme, E2P is transformed to the E1 state, as P is lost to the cytoplasm and the Ca 2+ binding sites are reoriented from low-affinity to high-affinity.
Structure and Function of Phospholamban
The -adrenergic action of catecholamines represents a key control mechanism that regulates the metabolic, electrical, and mechanical performances of cardiac muscle. cAMP, synthesized by the -adrenergic activation of adenylate cyclase, is the major intracellular messenger that mediates the stimulatory effects of the sympathetic nervous system. Increased concentrations of cAMP result in activation of PKA, which catalyzes phosphorylation of a number of functional proteins within cardiac myocytes. Besides catalyzing phosphorylation of phosphorylase kinase and glycogen synthetase, resulting in a marked increase in glycogenesis and glycolysis, the EC coupling processes are altered by cAMP through PKA-catalyzed phosphorylation of key proteins, particularly 'Ca 2+ cycling proteins'. 17, 18 In cardiac muscle SR, a 52-aa integral membrane protein phospholamban (PLN) with Mr of 6,080 is phosphorylated by PKA; the phosphoprotein exhibits the stability characteristics of a phosphoester 3, 5 and is subsequently determined to occur at its serine residue (Ser 16 ). This phosphorylable protein is a key protein linking 2 intracellular messengers, Ca 2+ and cAMP, serving as a modulator of the Ca 2+ -ATPase. 
Moleular Structure of Phospholamban
Phospholamban was first identified as a substrate for PKA in canine cardiac muscle SR, and was postulated to function as a regulatory factor of Ca 2+ -ATPase. 3 Radioelectrophoretogram indicated that [ -P]-phosphate is exclusively incorporated into a SR protein of 22-27 kDa, 19 forming an alkali-and acid-stable phosphoprotein unlike the phosphoenzyme intermediate (EP) of ATPase, which is stable in acid but unstable in alkali. 20 Furthermore, monomer -pentamer conversion of this protein was suggested to occur in the presence of sodium dodecylsulfate (SDS) in a temperature-dependent manner and in parallel with the phosphate incorporation. The purification and characterization of this molecule was performed by the Tada and Jones laboratories 21, 22 with the use of non-ionic detergents. The formation of a tight complex between and SERCA2a was considered to have precluded the purification of PLN. The amino acid sequence analyses by both chemical and cDNA cloning methods revealed that the monomer peptide consists of 52 residues, 23 with an estimated Mr of 6,080 (Fig 3A) . This finding confirmed that the observed conversion between higher (~30 kDa) and lower (~61 kDa) Mr species is because of formation of a homopentamer, which was stable in SDS at ambient temperature. The particle size in C12E8, subsequently estimated by low-angle laser diffraction studies, indicated that the majority of PLN exists as a pentamer of Mr 30,400. 24 The PLN monomer is organized into 3 physical and functional domains (Fig 3B) . Circular dichroism analysis indicated that this molecule is rich in -helices; 2 helices (domains IA and II) are connected by a less structured domain IB. Domain IA, consisting of residues 1-20, of which the majority is likely to be in an -helical conformation, and domain IB, consisting of residues 21-30 and likely to be less structured, constitute the cytoplasmic sector. Domain II, consisting of residues 31-52, represents the trans-membrane sector, made up solely of uncharged residues in anhelical conformation, and contains specific residues responsible for stabilizing the pentamer formation. These findings were in accord with the data from analysis of the pentamer stability by electron paramagnetic resonance. 25 Ser 16 and Thr 17 are the confirmed sites for PKA-and CaM kinasecatalyzed phosphorylation, respectively, which is in accord with a consensus sequence Arg-Arg-X-Ser-Thr 17 for the PK substrate. The existence of Pro 21 at the top of domain IB indicates the potential importance in the functional expression of this molecule, as this residue usually serves as a hinge in rotational motion and segment rearrangement.
Domain II contains the essential residues for oligomeric organization, because trypsinized PLN, which is devoid of most of domain I, remains pentameric. Three Cys residues (Cys 36 , Cyc 41 , and Cys 46 ), which lie at every 5 residues in an -helix, exist as free SH groups rather than forming disulfide bonds during pentamer formation. 1 It was predicted that the hydrophobic residues form a 3.5 residue/turn helix, 1 which allowed construction of a model of the interacting surfaces in which the helices are associated in a lefthanded pentameric coiled configuration. Mutation of the hydrophobic residues Ile 40 , Leu 43 , and Ile 47 destabilizes the pentamer, consistent with the view that these residues are critical to homo-pentameric formation. Further mutational study of domain II indicated that the predicted coiled structure is stabilized by a leucine zipper motif formed by close packing of Leu 37 , Ile 40 , Leu 44 , Ile 47 , and Leu 51 . 26 Consistent with this notion are the data obtained by structural analysis using electron paramagnetic resonance spectra, in which oligomeric proteins show decreased spin-labeled mobility compared with momers. Compared with wild-type PLN, PLN with Leu 37 mutated to Ala increases its mobility, 25 in accord with the previous data that this PLN mutant is predominantly monomeric.
Effect of PLN on the Reaction Sequence of SERCA1 Ca 2+ -ATPase
When PLN is phosphorylated by PKA, the rates of Ca 2+ uptake and ATP hydrolysis are accelerated with the coupling ratio maintained the same as a control. 4 Because there is no alteration of EP concentration in the saturating concentrations of Ca 2+ and ATP, the enhancement of Ca 2+ -ATPase activity is considered to be caused by the acceleration of the turnover of the ATPase enzyme. 3, 27 Studies of the partial reactions of ATPase coupled with Ca 2+ translocation, have been extensive. 3, 5 The rate of E1P formation is enhanced by PLN phosphorylation when the ATPase reaction is initiated by adding ATP and Ca 2+ to a reaction medium already containing EGTA. The rate of E1P formation is not altered significantly when ATP is added to a reaction medium already containing Ca 2+ . Thus, the effect of PLN phosphorylation is manifest in the formation of E1 from E2 (step i in Fig 2) , the rate-limiting step in E1P formation. The rate of E1P decomposition is also markedly Fig 3. (A) Comparison of the amino acid sequence of the phospholamban monomer. (B) Secondary structure of canine phospholamban monomer. The 2 -helices, domain Ia and domain II, are connected by domain Ib, which forms a random structure. Domain I is exposed at the cytoplasmic surface, whereas domain II is anchored in the SR membrane. The circled residues S and T represent Ser16 and Thr17 which are phosphorylated by cAMP-dependent and Ca/calmodulindependent protein kinase, respectively. accelerated by PLN phosphorylation, 5 indicating that the transition from 2Ca 2+ iE1P to E2P (step iii), the rate-limiting step during E1P decomposition, is also accelerated. Thus, the 2 rate-limiting steps, the transition from E2 to E1 states and the transition from E1 to E2 states in the E1 -E2 model are greatly enhanced when PLN is phosphorylated by PKA. It is of interest to note that PLN phosphorylation enhances the 2 rate-limiting steps in the reaction cycle of ATPase in which significant conformational changes occur in Ca 2+ -ATPase, bringing about alterations in the Ca 2+ affinity. These lines of evidence suggest that PLN may directly interact with SERCA2 through protein-protein interactions. 3 
Molecular Mode of Protein -Protein Interactions in the PLN-SERCA2 System
Protein -protein interactions occur between SERCA2a and PLN, which are dependent on the phospho-and dephospho-states of PLN. As has been reviewed extensively, 1,3 the proteins remain associated with each other after solubilization of the mirosomes; a monoclonal antibody against PLN disrupts the inhibitory effects of PLN on the SERCA2a Ca 2+ -ATPase activity; in the reconstitution system, using liposomes, the inhibitory effect of PLN can be observed; and when SERCA2a and PLN are coexpressed in heterologous cell culture, PLN inhibition of Ca 2+ -ATPase activity is observed.
Cytoplasmic Interaction of PLN and SERCA2
Employing the Denny-Jaffe crosslinking agent to conjugate purified PLN with SERCA2a, it was found that the complex is formed only when PLN is in the dephosphorylated state and SERCA2a is Ca 2+ -free. 27 Isolation and amino acid sequencing of the photoaffinity-labeled peptide from SERCA2a and SERCAla showed that Lys 397 and Lys 400 , which are located just after phosphoenzyme active site (Asp 351 ) in the SERCAs, are photolabeled. The functional significance of this sequence for PLN interaction was confirmed by measuring the effects of synthetic peptides covering this sequence of SERCA2a activity. 28, 29 In the presence of synthetic peptide, the Ca 2+ transport activity of cardiac SR (SERCA2a), but not that of fast-twitch skeletal muscle SR (SERCAla), was accelerated. As the major difference between the 2 types of SR is the presence or absence of PLN, it suggests that this peptide competes with cardiac Ca 2+ -ATPase for PLN, resulting in the de-inhibition of Ca 2+ -ATPase activity. Analysis of amino acid residues in the phosphorylation domain of SERCA1, SERCA2, and SERCA3 showed that the amino acid sequence of the putative PLN binding region is nearly identical in SERCA1 and SERCA2, but not in SERCA3 (Fig 4) . When Ca 2+ uptake rates for the 3 SERCA isoforms, coexpressed with or without PLN in COS-1 cells, are measured, the inhibitory effect of PLN on Ca 2+ affinity is observed with SERCA2 and SERCA1, but not with SERCA3 (Fig 5, panel A) . 30 The reason why in the SR of fast-twitch skeletal muscle, expressing SERCA1, but not PLN, while SERCA1 exhibits PLN binding sequence, is not known. It is plausible, however, that, during the differentiation of muscles, transcription of the PLN gene is dissipated, while the PLN binding sequence remains in SERCA1.
A series of chimeric Ca 2+ -ATPase between SERCA2 and SERCA3 was constructed and used in a co-expression system with COS-1 cells to identify the region functionally essential for the PLN interaction (Fig 5, panel B) . Microsomal fractions of COS-1 cells containing expressed proteins were subjected to assays for Ca 2+ uptake at different Ca 2+ concentrations. When Ca 2+ -dependence profiles of wild-type SERCAs co-expressed with or without PLN were compared, the affinity of SERCA2 for Ca 2+ was distinctly lowered by co-expressed PLN, whereas no effect was seen in SERCAs, in accord with sequence data (Fig 4) . In 2 chimeras, CH2 and CH9, no action of PLN was seen. Whereas no sensitivity to PLN was expected to occur in CH2, which is devoid of a PLN-binding region, it seems paradoxical not to see PLN-sensitivity in CH9, in which the PLN-binding sequence of SERCA2 was incorporated into the remainder of the SERCAs. These results indicated that a second type of interaction is required for full functional alterations. When the CH2 chimera was serially mutated back to the wild-type sequence, particularly within those sequences corresponding to the putative PLN-binding region, the sensitivity to PLN was evidently restored, as typically seen in CH2-M (Fig 5, panel C) , in which residues 397-402 were mutated back to Lys-Asp-Asp-Lys-ProVal 402 (KDDKPV), the original SERCA2 sequence. 31 As the Ca 2+ -dependence profile of CH2-M co-expressed with PLN exactly resembled that of wild-type SERCA2, the microsomes containing expressed CH2-M and PLN were assayed for Ca 2+ uptake in the presence and absence of PKA and MgATP to phosphorylate PLN. Under these conditions, phosphorylation of PLN resulted in a marked stimulation of Ca 2+ -uptake by microsomes containing CH2-M, indicating that the residues KDDKPV (V being a constant but essential residue) represent the essential functional region at the cytoplasmic level that interacts with PLN, presumably domain IA.
Mutant PLNs with replacement of amino acid residues in domain I were constructed and used to identify the region that is functionally essential for the SERCA2 interaction at the cytoplasmic level. 32 Ca 2+ -dependence profiles of SERCA2 co-expressed with wild-type or mutant PLN were measured for the isolated microsomal fraction of transfected cells. Functional consequences of PLN mutants demonstrated that loss of inhibitory function occurs at positively and negatively charged residues and hydrophobic residues in domain IA of PLN (Fig 6) . On the basis of the predicted structural model of domain IA, charged residues are clustered on one face of an -helical wheel, while hydrophobic residues are on the opposite face. Therefore, these 2 faces might interact with a reciprocal interacting surface of the cytoplasmic region of SERCA2.
Transmembrane Interaction of PLN and SERCA2
The enzyme kinetics in a reconstituted system in which purified SERCA2 and synthesized PLN were incorporated into liposomes have demonstrated that PLN peptides inhibit Ca 2+ transport by SERCA2 into the lipid vesicles. 28, 29 The cytoplasmic domain peptides decreased the Vmax at high molar excess over SERCA2. In contrast, transmembrane domain peptides decreased the Ca 2+ affinity of SERCA2 in the reconstituted systems. Thus, PLN may serve to inhibit the Ca 2+ affinity for SERCA2 through direct interaction between the transmembrane parts of the 2 proteins.
In a more direct evaluation of potential transmembrane interaction sites, 33, 34 PLN transmembrane segments fused with the cytoplasmic epitopes were constructed and co-expressed with SERCA2 in HEK293 cells. When the Ca 2+ -dependence profile of SERCA2 was measured for the isolated microsomal fraction of transfected cells, the inhibitory interaction site was found to be localized in the transmembrane sequence of PLN, indicating the existence of PLN interaction with SERCA2 at the transmembrane level. 33 To characterize these inhibitory actions. Leu 31 to Leu 52 of the PLN domain II were mutated and co-expressed with SERCA2, and then the Ca 2+ dependence of Ca 2+ transport was measured for the isolated microsomal fraction of the transfected cells. 34 The functional effects of different PLN mutants on Ca 2+ -dependence profile of SERCA2 are classified as 3 types (Fig 6) . Compared with wild-type PLN, no change in the Ca 2+ -dependence profile is found in the first type of mutations (no change mutants). The second type of mutations completely abolish the inhibitory actions on Ca 2+ affinity of SERCA2 (loss of function mutants), and the third type of mutations enhance the inhibitory effect, resulting in a more marked shift of the Ca 2+ -dependence profile to higher Ca 2+ concentrations (gain of function mutants or 'super shifters'). As indicated in the helical wheel configuration of domain II, loss of function is associated with mutations on one face of the helix, whereas gain of function is associated with mutations on the opposite face. As the majority of PLN is know to exist as a pentamer, 24, 35 it is of the utmost importance to define how the monomer -pentamer conversion relates to the PLN -SERCA2 interactions. More recently, evidence for physical interactions at the transmembrane level was obtained, employing alanine-scanning mutagenesis combined with assays for Ca 2+ -dependence profile for co-expressed PLN domain II mutants and SERCA1a (which contain PLN-binding sequence) transmembrane mutants. 36, 37 Those results sup- ported the view that PLN domain II directly interacts with transmembrane segments M6 of SERCAla.
Molecular Mechanism of the Control of SERCA2 by PLN
The interaction between PLN and SERCA2 can be regulated by the phosphorylation state of PLN. PLN is an active inhibitor only if the net charge in domain IA is +1 or +2. 32 The charge in the corresponding KDDKPV 402 sequence of SERCA2 is also important in the interaction. 31 Thus the reduction of net charge to -2 or less by phosphorylation of Ser 16 and/or Thr 17 has a deleterious effect on PLN function. Phosphorylation of Ser 16 has been shown to alter the accessibility of PLN to proteinases, 38 implying that conformational change must occur in the cytoplasmic part of PLN. Studies using circular dichroism analysis have also supported the view that conformational change occurs following phosphorylation. 39 These conformational changes may also affect the functional interaction between PLN and SERCA2. Unphosphorylated PLN suppresses the Ca 2+ -ATPase activity by binding to discrete sequences in the SERCA2 protein. Suppression is reduced by phosphorylation of PLN, which induces changes in both its net charge and its conformation. These changes result in its dissociation from and activation of the Ca 2+ -ATPase (Fig 7) .
The majority of PLN exists in the form of a pentamer 24 and it is of the utmost importance to define how the monomer -pentamer conversion relates to the PLN -SERCA2 interaction. Measurement of the maximal incorporation of phosphoryl groups into the Ca 2+ -ATPase and PLN resulted in the calculation of a stoichiometry of one PLN monomer per Ca 2+ -ATPase monomer. 4 By contrast, Colyer and Wang calculated a ratio of 2 moles of PLN per 1 mole of Ca 2+ -ATPase monomer. 40 Mutations of domain II of PLN provide insights into the stoichiometry of these proteins in the functional PLN-SERCA2 unit. 34 The formation of a pentamer is considered to occur through domain II of PLN. Residues in this domain exhibit functionally polarized localization on a helical wheel model. When the stability of a pentamer was estimated by its mobility in SDS-PAGE, wild-type PLN was approximately 75% pentameric and 25% monomeric. A study using fluorescence energy transfer revealed that 7-23% of the PLN subunits are monomeric in lipid membranes. 41 Gain of function mutants with a 2.5-fold increase in inhibitory function accompanied 3-to 4-fold enhancement of monomer formation, suggesting that gain of function may be a direct consequence of enhanced monomer formation. In loss of function mutants, the pentamer stability remained unchanged compared with wildtype PLN, suggesting that the interacting surface for SERCA2 lies on one face of the helix; that is, the exterior face of each helix in a PLN pentamer. 34 Thus, PLN monomers are considered to represent the functional form, whereas PLN pentamers function as a reservoir for the active monomer, leading to the proposal that the key determinant of inhibitory function is the concentration of inhibitory PLN monomer-SERCA2 complexes 34 (Fig 8) . More importantly, studies using alanine-scanning mutagenesis indicate the possibility that the domain II helix of PLN is in direct contact with the M6 helix of SERCA2. 36 Transmembrane M6, with its neighboring M4 and M5, has been shown to consist of a pore for Ca 2+ ; 2 moles of Ca 2+ ions are bound and fixed in this pore during the transport cycle.
Physiological and Pathophysiological Relevance of the PLN -SERCA2 System
During -adrenergic stimulation, catecholamines have 2 major effects on the myocardium: increased contractility and abbreviation of systole, 2,3 which are physiologically termed as the positive inotropic effects. When intracellular Ca 2+ concentrations are measured with aequorin, there is Ca 2+ release from cardiac SR during the early phase of contraction, as well as an enhancement of the rate of Ca 2+ removal from the cytoplasm at the onset of relaxation. When skinned cardiac cells, which exhibit cycles of phasic contraction upon addition of Ca 2+ , are preincubated with cAMP, these cells show an increased amplitude of contraction and faster rates of tension development and relaxation. 42 These effects of catecholamines on myocardial cell contractility are considered to result from cAMP and PKA effects on Ca 2+ fluxes across the SR and sarcolemmal membranes of myocardial cells. 1 Ca 2+ flux through Ca 2+ channels in the sarcolemmal membrane is activated by PKA. 1 This 'trigger' Ca 2+ accelerates Ca 2+ -induced Ca 2+ release from SR, thus increasing the rate and extent of myofibrillar contraction. The onset of increased tension after exposure of the heart to catecholamines is gradual, reaching the steady state after approximately 20 beats. 43 Ca 2+ uptake through the SR Ca 2+ -ATPase (SERCA2) is accelerated by PKAmediated phosphorylation of PLN, which reverses the inhibitory effect of PLN on the SERCA2 activity.
'Calcium Cycling Defects Cause Myocardial Hypertrophy and Failure': An Evolving Concept
Nagai et al showed that the expression of SERCA2 and PLN mRNA is altered in response to pressure overload and thyroid hormone. 44 Gene-targeted ablation of PLN, which was first demonstrated by Kranias et al, indicated that ablation of PLN results in the positive inotropic effects in the absence of -adrenergic stimulation. 45 More striking findings were made by Chien et al, who showed that in a well characterized mouse model of dilated cardiomyopathy, which has a deficiency in a cytoskeletal protein, the muscle-specific LIM protein (MLP) can be rescued by gene-targeted ablation of PLN. 46 They also suggested that a therapeutic effect is brought about by the elimination of the inhibitory effect of PLN on SERCA2, which eventually normalizes the critical calcium cycling defect, the apparent cause in producing the phenotype that resemble human heart failure. These intriguing findings were followed by MacLennan et al who demonstrated that a series of gain of inhibitory function mutants of PLN (super shifters) expressed in mice hearts in vivo significantly reduce the rate of Ca 2+ uptake by inhibiting the inherent SERCA2 activity. 47 Physiological assessments for the cardiovascular functions in these mice indicated the development of cardiac hypertrophy and failure. Recent studies by Tada et al using gene-targeted mutation of PLN-binding residues of SERCA2 (K 397 E and K 400 E) showed a significant augmentation of Ca 2+ uptake, which accompanied the attenuation of pressure-overload cardiac hypertrophy, suggesting that the prevention of PLN access to SERCA2 would preclude the occurrence of 'Calcium Cycling Defect' in the pressure-overloaded heart. Taking all of these results into consideration, it is quite likely that 'Calcium Cycling Defect' primarily occurs when Ca 2+ fluxes in the cardiac SR are severely perturbed, eventually causing functional, and even structural, dysfunction of the myocardial cells. Further studies should reveal more detailed insights into the molecular mechanisms by which cardiac hypertrophy/failure is caused by 'Calcium Cycling Defect' in cardiac SR proteins and related functional organellar units.
